Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer
ConclusionsNivolumab has a relatively favorable efficacy and safety profile for Japanese metastatic renal cell cancer patients in clinical practice.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | Cancer | Cancer & Oncology | Cancer Therapy | Japan Health | Kidney Cancer | Renal Cell Carcinoma | Statistics